Pexidartinib: First Approval

• Active surveillance of diffuse-type tenosynovial giant cell tumors: A retrospective, multicenter cohort study

  2024 European Journal of Surgical Oncology article Medicine Musculoskeletal synovial abnormalities and treatments Open access

  11

  citations
• Tenosynovial Giant Cell Tumor Observational Platform Project (TOPP) Registry: A 2-Year Analysis of Patient-Reported Outcomes and Treatment Strategies

  2023 The Oncologist article Medicine Musculoskeletal synovial abnormalities and treatments Open access

  12

  citations
• One-Stage Synovectomies Result in Improved Short-Term Outcomes Compared to Two-Stage Synovectomies of Diffuse-Type Tenosynovial Giant Cell Tumor (D-TGCT) of the Knee: A Multicenter, Retrospective, Cohort Study

  2023 Cancers article Medicine Musculoskeletal synovial abnormalities and treatments Open access

  4

  citations
• Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts

  2022 Cancer Treatment Reviews article Medicine Musculoskeletal synovial abnormalities and treatments Open access

  118

  citations
• Pexidartinib improves physical functioning and stiffness in patients with tenosynovial giant cell tumor: results from the ENLIVEN randomized clinical trial

  2021 Acta Orthopaedica article Medicine Musculoskeletal synovial abnormalities and treatments Open access

  24

  citations

5 results